UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting ...

Professor Peter Johnson, NHS National Clinical Director for Cancer, said: “This cutting-edge therapy has shown real promise in trials and could give patients with this aggressive form of leukaemia a ...

A stone's throw from Dublin's Merrion Square, where medical luminaries such as William Stokes and William Wilde plied their ...

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: ...

The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...

Scientists are uncovering what makes some carcinomas so resistant: their ability to change identity. Two new studies reveal ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the ...

Scientists have uncovered how leukemia cells manage to escape one of the most commonly used treatments. Over time, these ...

A “next generation” immunotherapy treatment that has the potential to cure leukaemia has been given NHS approval. Obe-cel is ...

Avis Favaro reports on a breakthrough form of therapy that is giving new hope to those suffering from glioblastoma, one of the most aggressive types of cancer.

Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted a federal priority-review request for its investigational SkinJect ...